Elevated cerebrospinal fluid beta-2 microglobulin as a tumor marker in a patient with myeloma of the central nervous system
Saudi Medical Journal. 2007; 28 (1): 128-130
em Inglês
| IMEMR
| ID: emr-85049
ABSTRACT
Myeloma involvement of the nervous system is rare. Extensive literature review revealed only a few cases reported from different parts of the world. The presence of CNS symptoms and detection of plasma cells in the CSF is the usual basis of diagnosis. In addition, immunoelectrophoresis and immunofixation for detection of monoclonal protein confirm the diagnosis in some cases, while some authors used flow cytometry and cytogenetic studies on CSF. Reports of multiple myeloma also include unfavorable cytogenetic abnormalities of chromosome 13. We report a case with relapsed CNS multiple myeloma with the detection of elevated beta-2 microglobulin [beta2M] as a tumor marker in the CSF
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Neoplasias Encefálicas
/
Biomarcadores Tumorais
/
Mieloma Múltiplo
Tipo de estudo:
Relato de Casos
Limite:
Feminino
/
Humanos
Idioma:
Inglês
Revista:
Saudi Med. J.
Ano de publicação:
2007
Similares
MEDLINE
...
LILACS
LIS